Abstract:Background CC chemokine receptor 9 (CCR9), an organ-specific chemokine receptor, interacts with its exclusive ligand CCL25 to promote tumor proliferation and metastasis. However, the effect of CCR9 on salivary adenoid cystic carcinoma (SACC) malignant behavior remains unknown. This study aimed to investigate the specific molecular mechanism by which CCR9/CCL25 modulates malignant progression in SACC. Methods Immunohistochemistry staining and RT–qPCR analyses were performed to detect the correlation of CCR9 expression and tumor progression-associated markers in SACC. In vitro , SACC cell proliferation and apoptosis were evaluated using Cell Counting Kit-8 and colon formation, and cell migration and invasion were detected by wound healing and transwell assays. Vercirnon was used as an inhibitor of CCR9, and LY294002 was used as an inhibitor of the PI3K/AKT pathway in this study. Western blot and RT–qPCR assays were carried out to measure the downstream factors of the interaction of CCL25 and CCR9. The effect of CCL25 on the development of SACC in vivo was examined by a xenograft tumor model in nude mice following CCL25, Vercirnon and LY294002 treatment. Results CCR9 was highly expressed in SACC compared with adjacent salivary gland tissues, and its level was associated with tumor proliferation and metastases. CCL25 enhanced cell proliferation, migration, and invasion through its interaction with CCR9 and exerted an antiapoptotic effect on SACC cells. Targeting CCR9 via Vercirnon significantly reduced the phosphorylation level of AKT induced by CCL25. CCL25/CCR9 could activate its downstream factors through the PI3K/AKT signaling pathway, such as cyclin D1, BCL2 and SLUG, thus promoting SACC cell proliferation, antiapoptosis, invasion and metastasis. The in vivo data from the xenograft mouse models further proved that CCL25 administration promoted malignant tumor progression by activating the PI3K/AKT pathway. Conclusion The interaction of CCL25 and CCR9 promotes tumor growth and metastasis in SACC by activating the PI3K/AKT signaling pathway, offering a promising strategy for SACC treatment.

CCL2/CCR2 Axis Promotes the Progression of Salivary Adenoid Cystic Carcinoma via Recruiting and Reprogramming the Tumor-Associated Macrophages.

CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via the PI3K/AKT signaling pathway

CCL2/CCR2 axis promotes perineural invasion of salivary adenoid cystic carcinoma via ITGβ5-mediated nerve-tumor interaction

CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis

Chemokine SDF-1α and Its Receptor Induce Chemotaxis and Invasion of Salivary Adenoid Cystic Carcinoma Cells

Expression of Tumor-Associated Calcium Signal Transducer 2 in Patients with Salivary Adenoid Cystic Carcinoma: Correlation with Clinicopathological Features and Prognosis.

Tumor-associated Macrophages Derived CCL18 Promotes Metastasis in Squamous Cell Carcinoma of the Head and Neck

Epha2 Silencing Promotes Growth, Migration, and Metastasis in Salivary Adenoid Cystic Carcinoma: in Vitro and in Vivo Study

Expression of Lc3, Lamp2, Keap1 and Nrf2 in Salivary Adenoid Cystic Carcinoma

AGR2 Promotes the Proliferation, Migration and Regulates Epithelial-Mesenchymal Transition in Salivary Adenoid Cystic Carcinoma

TAMs-derived exosomal Meg8 promotes the EMT and metastasis of SACC by regulating EGFR through sponge absorption of miR-148a-3p

TIM-3/Galectin-9 and CD160 Expression in Salivary Adenoid Cystic Carcinoma

The GAL/GALR2 axis promotes the perineural invasion of salivary adenoid cystic carcinoma via epithelial‐to‐mesenchymal transition

NR2F1 Contributes to Cancer Cell Dormancy, Invasion and Metastasis of Salivary Adenoid Cystic Carcinoma by Activating CXCL12/CXCR4 Pathway

Promoting SACC Invasion by TGF-β 1 805 MATERIAlS & METHODS Cell Culture

SCG2 Mediates HNSCC Progression With CCL2/TGFβ1high M2 Macrophage Infiltration

LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma

Tgf-Beta 1 Promotes Migration and Invasion of Salivary Adenoid Cystic Carcinoma

Author Response for "CASC9 Plays a Role in Salivary Adenoid Cystic Carcinoma in Vitro by Upregulation of ACLY"

Overexpression Cathepsin D Contributes to Perineural Invasion of Salivary Adenoid Cystic Carcinoma

CXCR5 induces perineural invasion of salivary adenoid cystic carcinoma by inhibiting microRNA-187